Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeAstellas Pharma Inc.

      Astellas Pharma Inc.

      Astellas States Fezolinetant Safety Information for Treating Menopausal Symptoms Over a Year
      Investing News

      Astellas States Fezolinetant Safety Information for Treating Menopausal Symptoms Over a Year

      September 5, 2022
      Verizon Business Selected to Transform the Global Network Infrastructure of Astellas Pharma
      Investing News

      Verizon Business Selected to Transform the Global Network Infrastructure of Astellas Pharma

      August 10, 2022

       

      LATEST NEWS

      • Investing News Reddit’s Q1 2026 Earnings Report Analysis
      • Investing News Rivian Adjusts Georgia Plant Plans
      • Investing News Stock Movements After-Hours Insights
      • Investing News Apple’s Stellar Quarter Amid CEO Change
      • Investing News Stellantis Q1 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026